4//SEC Filing
Weiland Robert J. 4
Accession 0001209191-17-053902
CIK 0001042074other
Filed
Sep 25, 8:00 PM ET
Accepted
Sep 26, 9:39 AM ET
Size
5.6 KB
Accession
0001209191-17-053902
Insider Transaction Report
Form 4
Weiland Robert J.
Director
Transactions
- Award
Stock Option (right to buy)
2017-09-22+7,500→ 7,500 totalExercise: $7.47Exp: 2027-09-21→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in 12 equal monthly installments commencing on June 1, 2017, subject to the Reporting Person's continuous service to the Issuer as of each such date. The option allows for early exercise by the Reporting Person.
Documents
Issuer
CymaBay Therapeutics, Inc.
CIK 0001042074
Entity typeother
Related Parties
1- filerCIK 0001670648
Filing Metadata
- Form type
- 4
- Filed
- Sep 25, 8:00 PM ET
- Accepted
- Sep 26, 9:39 AM ET
- Size
- 5.6 KB